There is a lack of high-quality evidence on what treatment should be used in children with properly characterised severe, therapy-resistant asthma. Data have to be largely extrapolated from trials in children with mild asthma, and adults with severe asthma.

Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where? PSACI (Problematic Severe Asthma in Childhood Initiative) group

Peroni, Diego;PIACENTINI, Giorgio
2011-01-01

Abstract

There is a lack of high-quality evidence on what treatment should be used in children with properly characterised severe, therapy-resistant asthma. Data have to be largely extrapolated from trials in children with mild asthma, and adults with severe asthma.
2011
Cyclosporin; long-acting β-agonist; methotrexate; omalizumab; prednisolone; steroid sparing
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/428584
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 41
social impact